Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines

Hans Prenen, Gunther Guetens, Gert De Boeck, Maria Debiec-Rychter, Patrick Schöffski, Allan T. Van Oosterom, Ernst A. De Bruijn

Cancer Res (2006) 66 (8_Supplement): 313–314.

Published: 15 April 2006

View article

Journal Articles

Resistance Patterns between cis-Diamminedichloroplatinum(II) and Ionizing Radiation

Christel M. J. De Pooter, Pierre G. Scalliet, Hilde J. Elst, John J. Huybrechts, Eric E. O. Gheuens, Allan T. Van Oosterom, Anne Marie J. Fichtinger-Schepman, Ernst A. De Bruijn

Cancer Res (1991) 51 (17): 4523–4527.

Published: 01 September 1991

View article

Journal Articles

Kinetics of the Formation and Removal of Cisplatin-DNA Adducts in Blood Cells and Tumor Tissue of Cancer Patients Receiving Chemotherapy: Comparison with in Vitro Adduct Formation

Anne Marie J. Fichtinger-Schepman, Saskia D. van der Velde-Visser, Helma C. M. van Dijk-Knijnenburg, Allan T. van Oosterom, Robert A. Baan, Frits Berends

Cancer Res (1990) 50 (24): 7887–7894.

Published: 01 December 1990

View article

Journal Articles

cis-Diamminedichloroplatinum(II)-resistant Sublines Derived from Two Human Ovarian Tumor Cell Lines

Peter J. K. Kuppen, Hanneke Schuitemaker, Laura J. van't Veer, Ernst A. de Bruijn, Allan T. van Oosterom, Peter I. Schrier

Cancer Res (1988) 48 (12): 3355–3359.

Published: 01 June 1988

View article

Journal Articles

cis-Diamminedichloroplatinum(II)-induced DNA Adducts in Peripheral Leukocytes from Seven Cancer Patients: Quantitative Immunochemical Detection of the Adduct Induction and Removal after a Single Dose of cis-Diamminedichloroplatinum(II)

Anne Marie J. Fichtinger-Schepman, Allan T. van Oosterom, Paul H. M. Lohman, Frits Berends

Cancer Res (1987) 47 (11): 3000–3004.

Published: 01 June 1987

View article

NARROW

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines

Resistance Patterns between cis-Diamminedichloroplatinum(II) and Ionizing Radiation

Kinetics of the Formation and Removal of Cisplatin-DNA Adducts in Blood Cells and Tumor Tissue of Cancer Patients Receiving Chemotherapy: Comparison with in Vitro Adduct Formation

cis-Diamminedichloroplatinum(II)-resistant Sublines Derived from Two Human Ovarian Tumor Cell Lines

cis-Diamminedichloroplatinum(II)-induced DNA Adducts in Peripheral Leukocytes from Seven Cancer Patients: Quantitative Immunochemical Detection of the Adduct Induction and Removal after a Single Dose of cis-Diamminedichloroplatinum(II)

Email alerts

AACR Journals

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines

Resistance Patterns between cis-Diamminedichloroplatinum(II) and Ionizing Radiation

Kinetics of the Formation and Removal of Cisplatin-DNA Adducts in Blood Cells and Tumor Tissue of Cancer Patients Receiving Chemotherapy: Comparison with in Vitro Adduct Formation

cis-Diamminedichloroplatinum(II)-resistant Sublines Derived from Two Human Ovarian Tumor Cell Lines

cis-Diamminedichloroplatinum(II)-induced DNA Adducts in Peripheral Leukocytes from Seven Cancer Patients: Quantitative Immunochemical Detection of the Adduct Induction and Removal after a Single Dose of cis-Diamminedichloroplatinum(II)

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only